// App-Quantinova.ai

POS15 : Evaluation of neointimal coverage one month after the zotarolimus-eluting stent implantation, using OCT

Researchers

Presenter

  • Munemasa M

Principal Investigators

  • Matsubara H

  • Ueeda H

  • Shigetoshi M

  • Tabuchi I

  • Hatanaka K

  • Arihara M

  • Miyaji K

  • Ogawa A

Medical Centers

  • Okayama Medical Center, Okayama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Multi-vessel disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved